Cutler Group LP Ardelyx, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 07, 2023	BUY	$1.22 - $2.85 $1,464 - $3,420	1,200 New	1,200 $0
Q1 2022 Apr 14, 2022	SELL	$0.65 - $1.18 $2,795 - $5,074	-4,300 Reduced 93.48%	300 $0
Q4 2021 Jan 18, 2022	BUY	$0.86 - $1.7 $3,612 - $7,140	4,200 Added 1050.0%	4,600 $3,000
Q3 2021 Oct 26, 2021	SELL	$1.27 - $8.17 $3,937 - $25,327	-3,100 Reduced 88.57%	400 $0
Q2 2021 Jul 19, 2021	BUY	$6.55 - $8.98 $19,650 - $26,940	3,000 Added 600.0%	3,500 $6,000
Q3 2019 Oct 28, 2019	SELL	$2.15 - $6.28 $9,675 - $28,260	-4,500 Reduced 90.0%	500 $0
Q3 2017 Oct 17, 2017	BUY	$4.35 - $5.7 $21,750 - $28,500	5,000	5,000 $0

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.